Neutralisation of Heparan Sulphate and Low Molecular Weight Heparin by Protamine

Summary

The neutralisation by protamine sulphate (PS) of heparan sulphate (HS), a low molecular weight heparin (LMWH), and a reference preparation of unfractionated heparin (UH), was studied by activated partial thromboplastin time (APTT) and anti-Xa clotting assays. UH was most easily neutralised in the APTT assay by PS (on a weight for weight basis), followed by LMWH and HS. The neutralisation of APTT activity by PS closely followed the loss of activity in the anti-Xa clotting assay, when plasma was used as the source of At III. When the anti-Xa clotting assay was carried out using purified At III in place of plasma, HS and LMWH were neutralised by much lower amounts of PS and resembled UH neutralisation more closely. Resistance of HS anti-Xa activity to PS neutralisation decreased with increasing plasma dilution. The presence of bovine albumin with purified At III concentrate increased the resistance of HS to PS neutralisation. It is concluded that PS binding to UH, HS and LMWH is probably related more to their degree of sulphation than molecular weight and that non-specific interactions between PS and plasma proteins inhibit the binding of PS to HS and LMWH.

Key words

Heparan sulphate - Low molecular weight heparin - Protamine sulphate - APTT - Anti-Xa activity

• References

• 1 Jorpes E, Edman P, Thaning T. Neutralisation of action of heparin by protamine. Lancet 1939; 2: 975-976
• 2 Michalski R, Lane DA, Pepper DS, Kakkar VV. Neutralisation of heparin in plasma by platelet factor four and protamine sulphate. Br J Haematol 1978; 38: 561-571
• 3 Thomas DP, Barrowcliffe TW, Merton RE, Stocks J, Dawes J, Pepper DS. In vivo release of anti-Xa clotting activity by a heparin analogue. Thromb Res 1980; 17: 831-840
• 4 Thomas DP, Merton RE, Barrowcliffe TW, Mulloy B, Johnson EA. Anti-Factor Xa activity of heparan sulphate. Thromb Res 1979; 14: 501-506
• 5 Teien AN, Abildgaard U, Höök M. The anticoagulant effect of heparan sulphate and dermatan sulphate. Thromb Res 1976; 8: 859-867
• 6 Hubbard AR, Jennings CA, Barrowcliffe TW. Anticoagulant properties in vitro of heparan sulphates. Thromb Res 1984; 35: 567-576
• 7 Johnson EA. Heparan sulphates from porcine intestinal mucosa: preparation and physicochemical properties. Thromb Res 1984; 35: 583-588
• 8 Thomas DP, Merton RE. A low molecular weight heparin compared with unfractionated heparin. Thromb Res 1982; 28: 343-350
• 9 Kakkar VV, Djazaeri B, Fok J, Fletcher M, Scully MF, Westwick J. Low-molecular weight heparin and prevention of postoperative deep vein thrombosis. Br Med J 1982; 284: 375-379
• 10 Andersson L-O, Barrowcliffe TW, Holmer E, Johnson EA, Sims GE. Anticoagulant properties of heparin fractionated by affinity chromatography on matrix bound antithrombin III and by gel filtration. Thromb Res 1976; 9: 575-583
• 11 Fischer A-M, Merton RE, Marsh NA, Williams S, Gaffney PJ, Barrowcliffe TW, Thomas DP. A comparison of pentosan polysulphate and heparin. II: Effects of subcutaneous injection. Thromb Haemostas 1982; 47: 109-113
• 12 Hoogendoom H, Cerskus A, Ofosu F, Blajchman M, Hirsh J. Preparation and partial characterisation of human plasma depleted of antithrombin III by heparin-Sepharose affinity chromatography. Thromb Res 1980; 20: 77-83
• 13 Graham DT, Pomeroy AR, Smythe DB. Measurement of the heparin neutralising capacity of protamine. Thromb Haemostas 1979; 41: 583-589
• 14 Holmer E, Söderström G. Neutralisation of unfractionated heparin and a low molecular weight (LMW) heparin fragment by protamine. Thromb Haemostas 1983; 50: 103 (Abstr.)
• 15 Massonnet-Castel S, Pelissier E, Dreyfus G, Deloche A, Abry B, Guibourt P, Terrier E, Passelecq J, Jaulmes C, Carpentier A. Low- molecular-weight heparin in extracorporeal circulation. Lancet 1984; 1: 1182-1183
• 16 Cobel-Geard RJ, Hassouna HI. Interaction of protamine sulfate with thrombin. Am J Hematol 1983; 14: 227-233
• 17 Kitani T, Nagarajan SC, Shanberge JN. Effect of protamine on heparin-antithrombin III complexes. In vitro studies Thromb Res 1980; 17: 367-374
• 18 Dawes J, Pepper DS. A sensitive competitive binding assay for exogenous and endogenous heparins. Thromb Res 1982; 27: 387-396